Logo wahanariau.com
  2. Obi pharma

Obi pharma

Index
Globenewswire

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies

Jumat, 06 Juni 2025 - 15:43:26 Wib
Globenewswire

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-902, a Trop-2 Targeting ADC

Kamis, 01 Mei 2025 - 20:17:42 Wib
Globenewswire

OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award

Rabu, 12 Maret 2025 - 22:06:41 Wib
Globenewswire

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

Senin, 23 Desember 2024 - 16:30:00 Wib
Globenewswire

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for Cancer Therapy

Kamis, 13 Juni 2024 - 09:44:05 Wib
Globenewswire

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

Rabu, 03 Januari 2024 - 17:30:00 Wib